Doug Besch - 01 Oct 2022 Form 3 Insider Report for OptimizeRx Corp (OPRX)

Role: Chief Product Officer
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol: OPRX
Transactions as of: 01 Oct 2022
Net transactions value: $0
Form type: 3
Filing time: 03 Oct 2022, 14:57:47 UTC
Next filing: 05 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OPRX	Common Stock						1,500	01 Oct 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	OPRX	Common Stock							01 Oct 2022	Stock Option	15,000	$50.99	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests in three equal annual installments beginning on June 1, 2022, which was the first anniversary of the date of grant.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.